Skip to main content
. 2017 Aug 15;9(8):3758–3775.

Table 2.

Recommended approach of RA treatment with DMARDs

• One or more DMARDs (preferably, a small molecule and a biologic)
• Principal short term objectives are symptom alleviation and prevention of joint damage
• Long term goals are to achieve remission or at least LDA
• Therapeutic efficacy should be assessed regularly and adjusted if response is low or absent
• No progression of radiologic features of joint destruction should be insured